Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MT1F | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | ARHGAP21 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | PFKM | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | HIST3H2BB | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | AMT | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | OTOP2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | LCLAT1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | LARS2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
mRNA | HECTD4 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | PSMB9 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |